Reaction
Urinary Tract Discomfort reporting signals
As of the last recalculation, Urinary Tract Discomfort appears in 447 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS (PRR 136.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Diltiazem Hydrochloride Extended-Release Tablets | 31 | 136.2 | 136.6 |
| Mometasone | 33 | 90.4 | 90.5 |
| Theophylline Anhydrous | 14 | 54.2 | 54.3 |
| Theophylline | 13 | 54.2 | 54.3 |
| Metformin Hydrochloride Tablets | 56 | 51.8 | 51.9 |
| Metformin Hydrochloride Extended-Release Tablets | 56 | 51.8 | 51.9 |
| Metformin Hydrochloride Tablet | 56 | 51.8 | 51.9 |
| Omalizumab | 78 | 51.4 | 51.5 |
| Metformin Hydrochloride | 56 | 50.2 | 50.3 |
| Diltiazem Hydrochloride | 31 | 44.8 | 44.8 |
| Mometasone Furoate | 34 | 41.0 | 41.1 |
| Atorvastatin Calcium, Film Coated | 46 | 33.9 | 33.9 |
| Piperacillin Sodium,Tazobactam Sodium | 16 | 29.1 | 29.1 |
| Copper | 4 | 4.4 | 4.4 |